Pages that link to "Q38332851"
Jump to navigation
Jump to search
The following pages link to Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages (Q38332851):
Displaying 50 items.
- Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells (Q28367621) (← links)
- Investigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular Dystrophy (Q28598287) (← links)
- Antisense approaches to the gene therapy of cancer--'Recnac'. (Q30426495) (← links)
- Kinetics study of the biotransformation of an oligonucleotide prodrug in cells extract by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. (Q30721969) (← links)
- Kinetics study of the biotransformation of an oligonucleotide prodrug in cells extract by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (Q30986281) (← links)
- Mechanism of cell transfection with plasmid/chitosan complexes (Q31004385) (← links)
- Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides (Q33607807) (← links)
- Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain (Q33804495) (← links)
- Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems (Q33864554) (← links)
- Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments (Q33916104) (← links)
- Novel non-endocytic delivery of antisense oligonucleotides (Q34062631) (← links)
- Alternative interpretations of the oligonucleotide transport literature: insights from nature (Q34062639) (← links)
- Inhibition of gene transcription by purine rich triplex forming oligodeoxyribonucleotides (Q34987749) (← links)
- Innovations in oligonucleotide drug delivery (Q35186336) (← links)
- The design and exogenous delivery of siRNA for post-transcriptional gene silencing. (Q35950928) (← links)
- DNA-based therapeutics and DNA delivery systems: a comprehensive review (Q36250777) (← links)
- Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA. (Q36316652) (← links)
- Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake (Q36711781) (← links)
- Cellular uptake and biological effects of antisense oligodeoxynucleotide analogs targeted to herpes simplex virus. (Q36819700) (← links)
- Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics. (Q37321859) (← links)
- Use of a Pteridine Moiety to Track DNA Uptake in Cells (Q37504497) (← links)
- Deoxyribozymes and bioinformatics: complementary tools to investigate axon regeneration (Q37970644) (← links)
- The Rossmann fold of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a nuclear docking site for antisense oligonucleotides containing a TAAAT motif. (Q38301046) (← links)
- Suppression of glioblastoma cell growth following antisense oligonucleotide-mediated inhibition of fibroblast growth factor receptor expression (Q38320161) (← links)
- Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates (Q38326062) (← links)
- Antisense oligonucleotides: Is the glass half full or half empty? (Q38341158) (← links)
- Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein (Q38347420) (← links)
- Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells. (Q38355750) (← links)
- Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells (Q39723434) (← links)
- Synthesis of phosphorothioate-methylphosphonate oligonucleotide co-polymers (Q40225889) (← links)
- An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers (Q40393595) (← links)
- Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells (Q40522457) (← links)
- Oligonucleotides with novel, cationic backbone substituents: aminoethylphosphonates (Q40523207) (← links)
- Regulation of endothelial cell adhesion molecule expression with antisense oligonucleotides (Q40625609) (← links)
- Therapeutic Potential and Mechanism of Action of Oligonucleotides and Ribozymes (Q40870551) (← links)
- Intracellular distribution of digoxigenin-labeled phosphorothioate oligonucleotides (Q40912612) (← links)
- Application of antisense DNA method for the study of molecular bases of brain function and behavior (Q41074275) (← links)
- Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3′-Alkylamino oligodeoxynucleotides, 2′-o-methyl oligoribonucleotides, oligodeoxynucleoside methylphosphonates, and peptide nucleic acids (Q41110040) (← links)
- Development of antisense and antigene oligonucleotide analogs. (Q41121288) (← links)
- Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides (Q41222315) (← links)
- Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice. An autoradiographic, immunohistological, and direct fluorescence microscopy study (Q42789464) (← links)
- Properties of Double-Stranded Oligonucleotides Modified with Lipophilic Substituents (Q42951476) (← links)
- Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor. (Q47801933) (← links)
- Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture (Q48029068) (← links)
- Intra-accumbens infusions of antisense oligodeoxynucleotides to one isoform of glutamic acid decarboxylase mRNA, GAD65, but not to GAD67 mRNA, impairs sustained attention performance in the rat. (Q48337407) (← links)
- The synthesis of modified oligonucleotides by the phosphoramidite approach and their applications (Q62029071) (← links)
- The Functionalization of Oligonucleotides Via Phosphoramidite Derivatives (Q62029073) (← links)
- Novel polyaminolipids enhance the cellular uptake of oligonucleotides (Q70826010) (← links)
- Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide (Q71058553) (← links)
- Dosimetry and optimization of in vivo targeting with radiolabeled antisense oligodeoxynucleotides: oligonucleotide radiotherapy (Q73190797) (← links)